Literature DB >> 10586037

The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.

V Loyer1, P Fontaine, S Pion, F Hétu, D C Roy, C Perreault.   

Abstract

The goal of this work was to evaluate the fate of APCs following interactions with T cells in unprimed mice with a normal T cell repertoire. We elaborated a model in which male adherent peritoneal mononuclear cells were injected into the foreleg footpads of naive female recipients mismatched for either minor or major histocompatibility Ags. At various times after injection, APC numbers in the draining (axillary and brachial) lymph nodes were assessed using a Ube1y gene-specific PCR assay. Our experimental model was designed so that the number of APCs expressing the priming epitope was similar to what is observed under real life conditions. Thus, early after injection, the frequency of afferent lymph-derived APCs expressing the priming epitope was in the range of 101-102/106 lymph node cells. We found that APCs presenting some, but not all, nonself epitopes were killed rapidly after entrance into the lymph nodes. Rapid elimination of APCs occurred following interactions with MHC class I-restricted, but not class II-restricted, T cells and was observed when APCs presented an immunodominant (B6dom1/H7a), but not a nondominant (HY), epitope. Killing of APCs was mediated partly, but not exclusively, by perforin-dependent process. We propose that killing of APCs by CTLs specific for immunodominant MHC class I-restricted epitopes may be instrumental in regulating the intensity, duration, and diversity of T cell responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586037

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.

Authors:  Jianping Yang; Stephanie P Huck; Rebecca S McHugh; Ian F Hermans; Franca Ronchese
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

2.  Jak3 negatively regulates dendritic-cell cytokine production and survival.

Authors:  Kunihiro Yamaoka; Booki Min; Yong-Jie Zhou; William E Paul; John J O'shea
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

3.  Mice deficient in perforin, CD4+ T cells, or CD28-mediated signaling maintain the typical immunodominance hierarchies of CD8+ T-cell responses to influenza virus.

Authors:  Weisan Chen; Jack R Bennink; Phillip A Morton; Jonathan W Yewdell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.

Authors:  Catherine E Terrell; Michael B Jordan
Journal:  Blood       Date:  2013-05-09       Impact factor: 22.113

5.  Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.

Authors:  Sabrina M Hess; Ellen F Young; Keith R Miller; Benjamin G Vincent; Adam S Buntzman; Edward J Collins; Jeffrey A Frelinger; Paul R Hess
Journal:  Transpl Immunol       Date:  2013-10-23       Impact factor: 1.708

6.  Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft models.

Authors:  Chihiro Koba; Miwa Haruta; Yusuke Matsunaga; Keiko Matsumura; Eriko Haga; Yuko Sasaki; Tokunori Ikeda; Koutaro Takamatsu; Yasuharu Nishimura; Satoru Senju
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

7.  CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cells.

Authors:  Mélissa Mathieu; Natacha Cotta-Grand; Jean-François Daudelin; Salix Boulet; Réjean Lapointe; Nathalie Labrecque
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 8.  Killing of dendritic cells: a life cut short or a purposeful death?

Authors:  F Ronchese; I F Hermans
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

9.  Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response.

Authors:  Reinhard Obst; Hisse-Martien van Santen; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2005-05-16       Impact factor: 14.307

10.  Inefficient boosting of antitumor CD8(+) T cells by dendritic-cell vaccines is rescued by restricting T-cell cytotoxic functions.

Authors:  Joel Zhi-Iong Ma; Jianping Yang; Jim S Qin; Antonia Richter; Rachel Perret; Wafik S El-Deiry; Niklas Finnberg; Franca Ronchese
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.